Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/jmv.28545 | DOI Listing |
Arch Soc Esp Oftalmol (Engl Ed)
April 2024
Servicio de Oftalmología, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain; Clínica Novovisión, Madrid, Spain.
Cornea
June 2023
Department of Ophthalmology, Casey Eye Institute, Oregon Health and Science University, Portland, OR.
Purpose: The aim of this study was to describe a case of corneal involvement as an early manifestation of ocular disease in the 2022 human mpox (monkeypox) virus outbreak.
Methods: This is a single case report with longitudinal care.
Results: A 47-year-old immunocompetent man presented with viral conjunctivitis before development of skin lesions or systemic symptoms.
J Med Virol
February 2023
Molecular Biology Laboratory, Biomedical Research Institute, Marcílio Dias Naval Hospital, Rio de Janeiro, Brazil.
J Fr Ophtalmol
February 2023
Service d'ophtalmologie, réseau OPHTARA, CHU Bicêtre Paris-Saclay, université Paris Saclay, AP-HP, Kremlin-Bicêtre, France; Département d'immunologie des maladies virales, auto-immunes, hématologiques et bactériennes, UMR1184, CEA Fontenay-Aux-Roses, France. Electronic address:
The current monkeypox virus (MPXV) outbreak, raging since May 2022, is the largest ever observed on a world-wide scale. Despite previously being endemic in west and central Africa with a mortality rate of up to 10%, it remained a neglected tropical disease. Along with other recent pandemics gaining much attention, this MPXV outbreak has provided an opportunity to improve our understanding of its physiopathology and better define management strategies, particularly in patients with more serious disease.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!